11,650 Shares in Chemed Co. (NYSE:CHE) Purchased by Trexquant Investment LP

Trexquant Investment LP acquired a new stake in shares of Chemed Co. (NYSE:CHE) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 11,650 shares of the company’s stock, valued at approximately $6,172,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CHE. CIBC Asset Management Inc boosted its position in shares of Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after purchasing an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC lifted its position in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after buying an additional 22 shares during the period. CIBC Private Wealth Group LLC boosted its holdings in shares of Chemed by 13.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company’s stock valued at $98,000 after buying an additional 22 shares in the last quarter. EP Wealth Advisors LLC grew its position in shares of Chemed by 1.9% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after buying an additional 25 shares during the period. Finally, Independent Advisor Alliance lifted its position in Chemed by 1.1% during the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after acquiring an additional 25 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CHE shares. Royal Bank of Canada upped their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.

Chemed Price Performance

Shares of Chemed stock opened at $598.17 on Friday. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $632.53. The firm’s 50-day moving average is $580.24 and its 200 day moving average is $568.11. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 30.23, a PEG ratio of 2.15 and a beta of 0.43.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is 10.05%.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. This trade represents a 0.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 3.32% of the stock is owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.